Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 235-120-4 | CAS number: 12070-08-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Carcinogenicity
Administrative data
- Endpoint:
- carcinogenicity: inhalation
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Study period:
- no data
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Meets generally accepted scientific standards, well documented and acceptable for assessment
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- publication
- Title:
- Pulmonary Responses of Rats Exposed to Titanium Dioxide (TiO2) by Inhalation for Two Years.
- Author:
- Lee, K.P.; et al.
- Year:
- 1 985
- Bibliographic source:
- Toxicol Appl Pharmacol 79:179-192
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Rats were exposed to TiO2 by inhalation exposure to concentrations of 0, 10, 50, and 250 mg/m³ for 6 h/day, 5 days/week for 2 years.
- GLP compliance:
- no
Test material
- Reference substance name:
- Titanium dioxide
- EC Number:
- 236-675-5
- EC Name:
- Titanium dioxide
- Cas Number:
- 13463-67-7
- IUPAC Name:
- dioxotitanium
- Test material form:
- not specified
- Details on test material:
- - Name of test material (as cited in study report): Titanium dioxide
- Substance type: inorganic
- Physical state: solid
- Analytical purity: not reported
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Crj: CD(SD)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Breeding Laboratories, Wilmington, Mass.)
- Age at study initiation: no data
- Weight at study initiation: no data
- Housing: no data
- Diet: ad libitum, Purina Rodent Chow
- Water: ad libitum
- Acclimation period: no data
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 23 +/- 2
- Humidity (%): 50 +/- 10
- Photoperiod: 12 hours dark/light cycle
No further details are given.
Administration / exposure
- Route of administration:
- inhalation: dust
- Type of inhalation exposure (if applicable):
- whole body
- Vehicle:
- air
- Details on exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: Plexiglas sample-feed tube attached to perpendicularly to the vertical axis of the elutriator.
- Method of holding animals in test chamber: tube
- Source and rate of air: no data
- Method of conditioning air: Elutriator
- System of generating particulates/aerosols: Atmospheres of TiO2 were generated by metering the dust into an apparatus containing a vertical elutriator (an inverted Plexiglas U-shaped tube) connected in series to a settling chamber. An Accu-Rate, variable-speed screw-feeder was used to meter TiO2 into a plexiglas sample-feed tube attached perpendiculary to the vertical axis of the elutriator. Dust was dispersed by an air-jet directed along the sample feed tube axis and passing into the elutriator. Initial settling of the heavier, nonrespirable dust fractions took place in the elutriator; the lighter fraction passed into the final settling chamber (a 50 l battery jar) from which the respirable fraction was diverted into the exposure chamber.
- Temperature, humidity, pressure in air chamber: no data
- Air flow rate: no data
- Air change rate: no data
- Method of particle size determination: no data
- Treatment of exhaust air: no data - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Chamber concentrations were determined gravimetrically.
- Duration of treatment / exposure:
- 24 month
- Frequency of treatment:
- 6 hours/day, 5 days/week
- Post exposure period:
- none
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
0 mg/m³
Basis:
nominal conc.
- Remarks:
- Doses / Concentrations:
10 mg/m³
Basis:
nominal conc.
- Remarks:
- Doses / Concentrations:
50 mg/m³
Basis:
nominal conc.
- No. of animals per sex per dose:
- A total of 400 male and female rats was divided into four groups of 100 males and 100 females each.
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale: results from previous inhalation studies
- Rationale for animal assignment (if not random): no data
- Rationale for selecting satellite groups: no data
- Post-exposure recovery period in satellite groups: no data
- Section schedule rationale (if not random): no data - Positive control:
- no data
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: no data
DETAILED CLINICAL OBSERVATIONS: Yes
BODY WEIGHT: Yes
- Time schedule for examinations: no data
FOOD CONSUMPTION:
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: No data
FOOD EFFICIENCY:
- Body weight gain in kg/food consumption in kg per unit time X 100 calculated as time-weighted averages from the consumption and body weight gain data: No
WATER CONSUMPTION: No
OPHTHALMOSCOPIC EXAMINATION: No
HAEMATOLOGY: No
CLINICAL CHEMISTRY: No
URINALYSIS: No
NEUROBEHAVIOURAL EXAMINATION: No - Sacrifice and pathology:
- GROSS PATHOLOGY: Five males and five females from each group were killed at 3 and 6 month of exposure, and subsequently, 10 males and 10 females were killed after one year of exposure. At the end of the 2 year exposure all rats were killed. All rats were subsjected to gross and microscopic evaluation.
HISTOPATHOLOGY: Lung tissue was fixed with Bouin`s solution by intratracheal instillation under low pressure for light microscopy. The trachea, thyroid, adrenal glands, testes, and kidneys were fixed in Bouin`s solution. All other tissues were fixed in 10% formalin solution. Paraffin sections were stained by hematoxylin and eosin, modified trichrome, silver impregnation, and periodic acid-Schiff (PAS) methods. For TEM the excised lung samples were fixed in 3 % glutaraldehyde for approx. 1 h. Then they were rinsed in Millonig`s phosphate buffer, postfixed for 2 h at 4°C in 1 % osmium tetraoxide, dehydrated in alcohol, and embedded in Epon. 1 µm sections were stained with toluidine blue and used to locate areas for EM. For SEM lung samples were fixed overnight in 3 % glutaraldehydem rinsed in Millonig`s phosphate buffer and then postfixed in 1 % osmic acid for 2 h. The tissue samples were mounted on aluminium stubs, placed on a rotary device in a vacuum evaporator, and coated evenly with approx. 200 Â of gold-palladium. - Other examinations:
- no data
- Statistics:
- no specified
Results and discussion
Results of examinations
- Clinical signs:
- effects observed, treatment-related
- Mortality:
- mortality observed, treatment-related
- Body weight and weight changes:
- effects observed, treatment-related
- Food consumption and compound intake (if feeding study):
- not specified
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not specified
- Behaviour (functional findings):
- not specified
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Gross pathological findings:
- effects observed, treatment-related
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Histopathological findings: neoplastic:
- effects observed, treatment-related
- Details on results:
- There were no abnormal clinical signs, body weight changes, or excess mortality in any exposed group when compared to control groups.
CLINICAL SIGNS AND MORTALITY : In the lungs of rats exposed to 10 mg/m³ white foci (< 1mm) were scattered sparsely throughout the pleural surface while a more dense accumulation of white foci was seen in the periphery of the lobes. At 50 mg/m³ these foci increased in number and size (< 2 mm). At 250 mg/m³ the lungs were voluminous and showed a white "paint brushed" appearance, contained rough pleural surfaces, and failed to collapse.
- significant increae of rhinitis, tracheitis, and pneumonia in all exposed rats. The severity of the lesions was dose-dependent.
BODY WEIGHT AND WEIGHT GAIN (See Table 1): Mean body weights of all TiO2-exposed groups were generally lower that those of the controls. Although there was no dose-related trend for these body weigh effects, the mean weights for male and female rats exposed to 250 mg/m^3 was consistently lower than those for rats exposed to 10 or 50 mg/m^3. The differences in the mean body weight gain among all treatment groups parallelled the mean body weight effects.
ORGAN WEIGHTS: The lung weights at 10 mg/m³ were comparable to those of the control group, but at 50 mg/m³, an increase in lung weights was statistically significant. The lung weights at 250 mg/m³ were more than twice the weight of control lungs. The tracheobronchial lymph nodes were markedly enlarged in a dose-related fashion and showed a white "chalky mass" appearance.
GROSS PATHOLOGY: During the gross pathological examinations, TiO2 deposits were observed on skin and the mucosa of the nasal cavity, trachea, bronchus and gastrointestinal tract of rats exposed to this compound. The pleural surfaces of the lungs contained scattered white foci which were present in greater numbers and larger sizes in rats exposed to the higher TiO2 concentrations. Subpleural cholesterol granulomas appeared on the lungs of rats in the 50 and 250 mg/m^3 treatment groups as slightly elevated gray nodules. The lungs of rats in the 250 mg/m^3 treatment groups were white in appearance, voluminous, of rubbery consistency and failed to collapse upon opening the chest cavity at necropsy.
The tracheabronchial lymph nodes were markedly swollen and appeared as chalky masses in all exposure groups. Most of these gross observations were apparent at six months with the severity and frequency of occurrence increasing over time.
HISTOPATHOLOGY: NON-NEOPLASTIC (see table 2): All TiO2 exposed groups showed slight increases in the incidences of pneumonia, tracheitis, and rhinitis with squamous metaplasia of the anterior nasal cavity.
The lung reaction was characterised by dust-laden macrophage (dust cell) infiltration in the alveolar ducts and adjoining alveoli with hyperplasia of Type II pneumocytes. Rats at 50 and 250 mg/m³ exposure revealed a dose-dependent dust cell accumulation, a foamy macrophage response, type II pneumocyte hyperplasia, alveolar proteinosis, alveolar bronchiolarisation, cholesterol granulomas, focal pleurisy, and dust deposition in the tracheobronchial lymph nodes. Minute collagenised fibrosis occurred in the in the alveolar walls enclosing large dust cell aggregates. The pulmonary lesions with massive dust accumulation appeared to be the result of an overwhelmed lung clearance mechanism at 250 mg/m³ TiO2 exposure.
HISTOPATHOLOGY: NEOPLASTIC: Bronchioloalveolar adenomas and cystic keratinising squamous cell carcinoma occurred at 250 mg/m³ TiO2 exposure (the tumours produced were ultimately characterised as primarily benign pulmonary keratin cysts (Warheit and Frame,2006)), while no compound-related lung tumours were found in rats exposed either to 10 or 50 mg/m³. - Relevance of carcinogenic effects / potential:
- According to the results of this study TiO2 is not considered to be a rodent carcinogen below particle overload conditions.
Effect levels
open allclose all
- Dose descriptor:
- NOAEC
- Effect level:
- 50 mg/m³ air (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Remarks on result:
- other: Effect type: carcinogenicity (migrated information)
- Dose descriptor:
- NOAEC
- Effect level:
- 10 mg/m³ air (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Remarks on result:
- other:
- Remarks:
- Effect type: other: non-neoplastic changes (migrated information)
Any other information on results incl. tables
Table1: Lung and final body weights of rats exposed to TiO2at 0, 10, 50, or 250 mg/m³.
Exposure concentration |
Final body weights |
Lung weight |
Lung/body weight ratio |
|||
Male |
Female |
Male |
Female |
Male |
Female |
|
0 mg/m³ (Control) |
780.0 |
557.1 |
3.25 |
2.35 |
0.44 (0.17)a |
0.43 (0.08) |
10 mg/m³ |
778.0 |
597.6 |
3.56 |
2.76 |
0.46 (0.18) |
0.47 (0.01) |
50 mg/m³ |
769.3 |
566.9 |
4.47* |
3.10* |
0.59 (0.09)* |
0.74 (0.18)* |
250 mg/m³ |
743.3 |
508.6 |
7.84* |
7.21* |
1.07 (0.16)* |
1.46 (0.39)* |
aStandard deviation
*Significantly different (p < 0.05) from control group by Dunnett`s test.
Table2: Incidence of main nonneoplastic lesions in the nasal cavity and trachea
|
Control |
10 mg/m³ |
50 mg/m³ |
250 mg/m³ |
||||
I (♂) |
II (♀) |
III (♂) |
IV (♀) |
V (♂) |
VI (♀) |
VII (♂) |
VIII (♀) |
|
Nasal cavity |
(79) |
(76) |
(71) |
(74) |
(73) |
(74) |
(76) |
(73) |
Rhinitis, anterior |
25 |
18 |
57 |
36 |
48 |
34 |
70 |
63 |
Rhinitis, posterior |
13 |
3 |
13 |
10 |
3 |
1 |
14 |
18 |
Sq. metaplasia, anterior |
8 |
7 |
26 |
14 |
20 |
21 |
44 |
40 |
Sq. metaplasia, posterior |
- |
1 |
- |
- |
- |
1 |
1 |
2 |
Trachea |
(79) |
(77) |
(68) |
(74) |
(74) |
(69) |
(77) |
(65) |
Tracheitis |
2 |
1 |
52 |
34 |
53 |
37 |
61 |
28 |
( ) the number of rats examined is in parentheses
Table3: Incidence of main nonneoplastic lesions in the nasal cavity and trachea
|
Control |
10 mg/m³ |
50 mg/m³ |
250 mg/m³ |
||||
I (♂) |
II (♀) |
III (♂) |
IV (♀) |
V (♂) |
VI (♀) |
VII (♂) |
VIII (♀) |
|
Lung |
(79) |
(77) |
(71) |
(75) |
(75) |
(74) |
(77) |
(74) |
Aggregates, foamy alveolar macrophage |
14 |
8 |
19 |
15 |
53 |
70 |
76 |
74 |
Alveolar cell hyperplasia, TiO2deposition |
- |
-- |
67 |
72 |
75 |
74 |
77 |
74 |
Alveolar proteinosis |
- |
- |
- |
- |
38 |
45 |
75 |
71 |
Bronchiolarization, alveoli |
1 |
1 |
- |
3 |
24 |
57 |
63 |
73 |
Broncho/bronchiolar pneumonia |
1 |
1 |
7 |
11 |
8 |
10 |
7 |
5 |
Cholesterol granuloma |
7 |
2 |
9 |
6 |
56 |
53 |
75 |
71 |
Collagenized fibrosis |
11 |
3 |
7 |
4 |
49 |
41 |
76 |
73 |
Pleurisy |
4 |
2 |
7 |
7 |
28 |
26 |
55 |
66 |
Anaplastic carcinoma, large cell |
- |
- |
1 |
- |
- |
- |
- |
- |
Bronchioalveolar adenoma |
2 |
- |
1 |
- |
1 |
- |
12 |
13 |
Squamous cell carcinoma |
- |
- |
- |
1 |
- |
- |
1 |
13 |
( ) In parentheses is the number of rats examined
Applicant's summary and conclusion
- Conclusions:
- A NOEC of Titanium dioxide of 50 mg/m³ for carcinogenicity, and a NOEC of 10 mg/m³ for non-neoplastic changes was established.
- Executive summary:
In a combined repeated dose and carcinogenicity study Titanium dioxide was administered to 400 male and female Crj: CD(SD) rats by inhalation at nominal concentrations of 0, 10, 50, and 250 mg/m³ 6 hours a day, 5 days a week for 24 month.
There were no abnormal clinical signs, body weight changes, or excess mortality in any exposed group. Exposed groups showed slight increases in the incidence of pneumonia, tracheitis, and rhinitis with squamous metaplasia in the anterior nasal cavity. The lung reaction was characterized by dust-laden macrophage (dust cell) infiltration in the alveolar ducts and adjoining alveoli with hyperplasia of type II pneumocytes. Exposure to 50 and 250 mg/m³ resulted in dose dependent dust cell accumulation, a foamy macrophage response, type II pneumocyte hyperplasia, alveolar proteinosis, alveolar brochiolarization, cholesterol granulomas, focal pleurisy, and dust deposition in the tracheobronchial lymph nodes. The pulmonary lesions with massive dust accumulation appeared to be the result of an overwhelmed lung clearance mechanism at 250 mg/m³ exposure., Bronchioloalveolar adenomas and cystic keratinizing squamous cell carcinomas occurred at 250 mg/m³ exposure.
Based on the findings at the low dose (alveolar cell hyperplasia, broncho/bronchiolar pneumonia) the concentration of 10 mg/m³ is considered as NOEC for non-neoplastic changes in this study.
Bronchioloalveolar adenomas and cystic keratinizing squamous cell carcinoma occurred at 250 mg/m³ TiO2 exposure (the tumours produced were ultimately characterized as primarily benign pulmonary keratin cysts (Warheit and Frame,2006)), while no compound-related lung tumors were found in rats exposed either to 10 or 50 mg/m³. Thus, the concentration of 50 mg/m³ represents the NOEC for carcinogenicity in rats.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.